The Strategic Role of Pass-Through Entities in the Maryland Research and Development Tax Credit Framework

Pass-through entities function as organizational structures—such as LLCs, partnerships, and S-corporations—that bypass corporate-level income taxation by shifting the tax burden directly to their owners or members. Within the landscape of the Maryland Research and Development (R&D) tax credit, these entities act as vital conduits that allow innovation-driven businesses to earn state-certified tax offsets at the entity level and distribute them to individual members to lower their personal Maryland income tax liabilities.1

The mechanism of the Maryland Research and Development tax credit represents a sophisticated interplay between state economic policy and the diverse corporate structures that define the modern innovation economy. While many tax credits are designed for large C-corporations with singular, centralized tax liabilities, Maryland’s program recognizes that a significant portion of the state’s burgeoning biotechnology, cybersecurity, and advanced manufacturing sectors is comprised of pass-through entities (PTEs). For these businesses, the credit is not merely a corporate deduction but a strategic asset that flows through to individual shareholders, partners, and members, providing a direct reduction in the state income tax they would otherwise owe on their distributive shares of the entity’s income.2 This structural transparency ensures that the incentive for research and development reaches the entrepreneurs and investors who are putting capital at risk to foster Maryland-based discovery. The governing authority for this program resides primarily in Maryland Tax-General Article § 10-721, supplemented by detailed regulations from the Maryland Department of Commerce and the Comptroller of Maryland, which together define the rigorous certification and reporting standards required to monetize these high-value tax attributes.5

Statutory Foundations and the Evolution of § 10-721

The Maryland Research and Development Tax Credit was established to incentivize businesses of all sizes to increase their investments in research conducted within the state’s borders. The program is currently authorized through June 30, 2027, highlighting a long-term commitment by the Maryland General Assembly to foster a competitive technical ecosystem.5 The legislative history of Tax-General Article § 10-721 reveals a gradual refinement of the credit’s focus, transitioning from a broad foundational incentive to a performance-based reward for growth.

Historically, the program offered two distinct tiers of credits: a “Basic” credit and a “Growth” credit. The Basic credit was designed to reward any qualifying research activity, providing a 3% credit on qualified research expenses (QREs) up to a defined “Maryland Base Amount”.7 This ensured that even companies maintaining a steady level of innovation received some measure of support. However, in response to shifting economic priorities and a desire to maximize the impact of every state dollar, the Maryland General Assembly passed Chapter 114 of the Acts of 2021.10 This pivotal amendment repealed the 3% Basic credit for all taxable years beginning after December 31, 2020. Consequently, the program now focuses exclusively on the “Growth” component, which offers a robust 10% credit on expenses that exceed the Maryland Base Amount.5

This legislative shift has significant implications for pass-through entities. Since PTEs often operate with leaner margins and more volatility than C-corporations, the concentration of the credit into a 10% growth incentive means that these entities must actively scale their R&D operations to capture the maximum benefit. The law defines “Maryland qualified research and development” as research defined under § 41(d) of the Internal Revenue Code (IRC) that is conducted physically within Maryland.5 This federal alignment creates a uniform standard for what constitutes “innovation,” requiring that activities be technological in nature, involve a process of experimentation, and aim to eliminate technical uncertainty regarding a new or improved business component.11

Pass-Through Entity Dynamics and Structural Eligibility

Maryland tax law recognizes several types of pass-through entities that are eligible to apply for and distribute the R&D tax credit. These include Subchapter S corporations, partnerships, limited liability companies (LLCs) not taxed as corporations, and business trusts.2 For these entities, the R&D credit is “earned” by the entity through its qualifying activities in Maryland, but it is “claimed” by the members who bear the ultimate tax liability.

The Mechanism of Flow-Through Allocation

When a pass-through entity is certified for an R&D tax credit by the Department of Commerce, it does not use the credit to offset its own tax liability, as the entity itself typically has no Maryland income tax liability (with certain exceptions for nonresident member tax or entity-level election tax). Instead, Regulation 03.04.10.02 dictates that the credit must be allocated among the partners, shareholders, or members.2 The allocation follows a specific hierarchy of rules:

1. Written Agreement: If the entity has a valid written agreement (such as an operating agreement or partnership agreement) that specifies the allocation of tax credits, that agreement governs the distribution.4 This allows for “special allocations” in some partnership contexts, provided they have substantial economic effect under federal principles.
2. Pro Rata Share: In the absence of a specific written agreement for credits, the credit is allocated in the same proportion as the owners’ shares of the entity’s profits and losses for the taxable year.2
3. Fiduciary Entities: For estates and trusts, the credit is apportioned between the fiduciary and the beneficiaries based on the amount of income allocable to each.4

This flow-through nature is particularly beneficial for Maryland residents who own pieces of multiple innovation-driven startups. The credits from various entities can be aggregated on the individual’s personal tax return (Form 502) to potentially wipe out their entire state tax liability.

The Election of Tax Treatment: Form 510 vs. Form 511

Recent changes in Maryland tax law have introduced a critical decision point for PTEs that impacts how the R&D credit is processed and reported. Entities must choose between filing as a standard PTE (Form 510) or making an election to pay tax at the entity level (Form 511).13

The standard Form 510 is an informational return. While the PTE must pay tax on behalf of its nonresident members, the tax is essentially a withholding mechanism, and the R&D credit is simply passed through via Schedule K-1 (510/511) to all members.2 However, under legislation effective July 1, 2021, many Maryland PTEs have opted to file Form 511. This “Electing PTE” status allows the business to pay the state income tax on all members’ shares of income at the entity level.13

For an Electing PTE, the R&D tax credit can be used to directly offset the entity-level tax before it is distributed to the members.13 This can simplify the tax lives of the members, as they receive a corresponding credit for the tax already paid by the entity, which is adjusted for the R&D credit applied at the source. The election to file Form 511 is made annually and is irrevocable once the first filing of the tax year is submitted.14

Calculation Methodology: The Maryland Base Amount

To qualify for the 10% Growth credit, a pass-through entity must first calculate its “Maryland Base Amount.” This figure represents the historical benchmark of the company’s research intensity within the state. The calculation is deeply rooted in federal § 41 principles but is localized through the use of Maryland-specific data points.5

The Fixed-Base Percentage

The first component of the base amount is the “fixed-base percentage.” For Maryland purposes, this is generally the percentage that the entity’s Maryland QREs for the four taxable years immediately preceding the credit year bear to the entity’s Maryland gross receipts for those same four years.1 If the entity has been in existence for fewer than four years, the calculation is adjusted to include only those years for which the entity was in business.1

$$\text{Fixed-Base Percentage} = \frac{\sum(\text{Maryland QREs for prior 4 years})}{\sum(\text{Maryland Gross Receipts for prior 4 years})}$$

Average Maryland Gross Receipts

The second component is the average Maryland gross receipts for the four taxable years preceding the credit year.1 “Maryland gross receipts” are defined as receipts from transactions where the property is delivered or the services are performed within the state. This requires PTEs to meticulously track their revenue sources to ensure an accurate calculation.

Final Base Amount and Growth Credit

The Maryland Base Amount is the product of the fixed-base percentage and the average gross receipts. The potential R&D credit is then calculated as 10% of the amount by which the current year’s Maryland QREs exceed this base.5

$$\text{Growth Credit} = 0.10 \times (\text{Current Year Maryland QREs} – \text{Maryland Base Amount})$$

For start-up entities—defined as those in their first year of incurring R&D expenses in Maryland—the base amount is zero. This allows the firm to claim a 10% credit on the entirety of its first-year Maryland research expenditures, providing a massive incentive for new technical ventures to establish roots in the state.6

The Small Business Distinction: Asset Caps and Refundability

A critical nuance for pass-through entities is the “small business” designation. In the context of the Maryland R&D credit, being classified as a small business transforms a non-refundable tax offset into a liquid cash refund—a vital distinction for pre-revenue or early-stage startups.1

The Asset-Based Definition

Maryland defines a “small business” for R&D purposes using a balance sheet test. To qualify, a for-profit corporation, LLC, partnership, or sole proprietorship must have net book value assets totaling less than $5 million at either the beginning or the end of the taxable year for which the credits are claimed.1

• Net Book Value: This refers to total assets (including intangibles like IP) minus accumulated depreciation and amortization.1 It is important to note that liabilities are not subtracted in this calculation; it is a measure of total asset scale rather than net equity.
• Verification: Small businesses must submit their balance sheet as part of the application to the Department of Commerce to prove they meet this threshold.1

The Power of Refundability

For larger entities, the R&D tax credit is non-refundable. If the credit exceeds the tax liability for the year, it cannot result in a check from the state. Instead, it must be carried forward to offset future taxes for up to 7 years.1 Historically, some regulations mentioned a 15-year carryforward, but current statutes and Commerce guidance emphasize the 7-year limitation.4

However, for a certified small business, the credit is fully refundable.1 If the credit amount exceeds the Maryland income tax liability of the small business for that year, the Comptroller will issue a refund check for the excess.5 For a pass-through entity, this refundability flows to the individual members. If a partner’s share of the R&D credit exceeds their personal Maryland tax liability, they are entitled to a refund.

Statutory Caps, Proration, and Competition for Credits

The Maryland R&D tax credit is not an open-ended entitlement. It is a “budgeted” credit with an annual statutory cap of $12 million.1 Because the program is routinely over-subscribed—meaning the total amount of credits applied for by all Maryland businesses exceeds $12 million—the Department of Commerce must employ a proration mechanism.1

The Allocation “Buckets”

The $12 million annual pool is divided into two segments to ensure that small businesses have a guaranteed share of the incentive:

If either bucket is under-subscribed, the unused funds can “spill over” into the other category.5 However, the reality of Maryland’s tech sector is that both categories are typically over-subscribed. In such cases, the Department of Commerce calculates a “proration factor” by dividing the statutory cap by the total amount of credits certified for all applicants in that category.6

The Impact of the $250,000 Per-Applicant Cap

Regardless of how much R&D a company performs, the Department of Commerce is prohibited by statute from approving a tax credit for any single applicant in an amount exceeding $250,000.5 For large pass-through entities with significant R&D budgets, this cap represents a hard ceiling on the state incentive. Furthermore, all members of a “controlled group” of businesses are treated as a single applicant for the purposes of this cap, preventing owners from splitting their business into multiple PTEs to claim multiple $250,000 credits.4

Local State Revenue Office Guidance: The Comptroller’s Rules

While the Department of Commerce certifies the credit, the Comptroller of Maryland governs how it is reported and claimed. For pass-through entities, this involves a series of technical requirements that must be followed to avoid audit triggers or the denial of the credit.

Electronic Filing Mandate

The Maryland Revenue Administration Division is strict regarding the method of filing for entities claiming business tax credits. Form 510 and Form 511 must be filed electronically if the pass-through entity has generated an R&D tax credit from Form 500CR to pass on to its members.2 If an entity files a paper return while claiming these credits without a certified hardship waiver (Form 500CRW), the credit may be rejected, and processing will be significantly delayed.2

The Add-Back Requirement (Tax-General § 10-205)

A frequent point of confusion for PTE owners is the “add-back” adjustment. Maryland law prohibits a taxpayer from receiving a double benefit for the same expenditure. Since R&D expenses are typically deducted from income on the federal return (which Maryland uses as a starting point for its own tax calculations), the state requires the taxpayer to add back the amount of the Maryland R&D credit to their Maryland adjusted gross income.9

For a pass-through entity, this means that the credit amount must be included as an addition to income on the state return of the member who is claiming the credit. This ensures that the credit serves as an offset to tax, not as an additional deduction of expenses.9

Amended Returns and the Timing of Claims

The R&D tax credit process is retrospective. Because the application for a 2024 credit is not filed until November 2025, and the certification letter is not issued until February 2026, the credit cannot be claimed on the original 2024 tax return.1

To monetize the credit, the taxpayer (the PTE member) must file an amended Maryland income tax return for the year in which the R&D expenses were incurred.1 The amended return must include Form 500CR and a copy of the final certification letter from the Department of Commerce. This procedural lag is a critical consideration for PTE cash flow management, as the benefit of the 2024 research activity may not result in a tax refund until well into 2026.

Comprehensive Example: Bio-Quest Maryland LLC

To illustrate the practical application of these regulations, consider the case of Bio-Quest Maryland LLC, a fictional biotechnology partnership based in Rockville, Maryland.

Entity Profile and Historical Data

Bio-Quest is a partnership with two equal partners: a Maryland resident and a nonresident entity. In late 2024, the business evaluates its R&D activities to prepare for the 2025 application cycle.

• Asset Test: On December 31, 2024, Bio-Quest’s balance sheet shows total assets of $6,000,000 and accumulated depreciation of $1,500,000.

• Calculation: Net book value = $6,000,000 – $1,500,000 = $4,500,000.
• Result: Bio-Quest qualifies as a “Small Business” (< $5M assets) and is eligible for refundable credits.1

• Historical R&D Context (2020-2023):

• Aggregate Maryland QREs: $1,600,000.
• Aggregate Maryland Gross Receipts: $20,000,000.
• Calculation: Fixed-Base Percentage = $1,600,000 / $20,000,000 = 8%.1

• Credit Year Data (2024):

• Average Maryland Gross Receipts (prior 4 years): $5,000,000.
• Current Year Maryland QREs: $1,200,000.

Step-by-Step Credit Calculation

1. Maryland Base Amount: 8% (Fixed-Base) x $5,000,000 (Avg Receipts) = $400,000.1
2. Growth Credit Calculation: 10% x ($1,200,000 – $400,000) = $80,000.6
3. Application Process: Bio-Quest submits an online application to the Department of Commerce by November 15, 2025, including its 2024 balance sheet and federal Form 6765.6
4. Proration and Certification: The Department of Commerce determines that the Small Business bucket is over-subscribed, resulting in a 90% proration factor for that year.1

• Certified Credit: $80,000 x 0.90 = $72,000.

1. Reporting to Members: Bio-Quest files its 2024 Form 510 electronically. It provides each 50% partner with a Maryland Schedule K-1 (510/511) showing a $36,000 R&D tax credit.2
2. Individual Claim: The Maryland resident partner files an amended 2024 Form 502. They add the $36,000 back to their income (as an addition) and claim a $36,000 credit.9 Because the credit is refundable for small businesses, if the partner’s tax liability was only $10,000, the Comptroller would issue a refund for the remaining $26,000.5

Compliance, Audit Preparedness, and Substantiation

The Department of Commerce and the Comptroller’s office reserve the right to audit any R&D tax credit claim. For pass-through entities, the risk is distributed; an audit of the entity’s records can lead to the disallowance of credits already claimed by its members.

Federal Alignment and the Substantiation Standard

Maryland adheres to the federal substantiation standards for QREs. This means that a PTE must be able to link its costs to specific “Qualified Research Activities” (QRAs). Guidance from professional advisors and regulatory trends suggests that entities should maintain the following documentation for at least four years 1:

• Employee Wage Nexus: Documentation (such as Innovation Logs or time tracking) that proves what percentage of each employee’s time was spent on R&D versus routine operations.12
• Supply Tracking: Invoices for supplies that were “consumed” in the R&D process, ensuring they were not for capital equipment (which is depreciated, not a QRE).12
• Contractor Oversight: For contract research, the PTE must show that it retained the “substantial rights” to the research and bore the “economic risk” of failure—and confirm the research was performed in Maryland.12

Common Pitfalls for Maryland PTEs

• Nexus Failures: Claiming wages for an employee who lives in Virginia or D.C. but works for a Maryland company. Maryland law is explicit: the research must be conducted in Maryland.5
• Incomplete Gross Receipts Tracking: Failing to properly exclude non-Maryland revenue from the gross receipts calculation, which can artificially lower the fixed-base percentage and lead to an audit adjustment.21
• Missing the November 15th Deadline: There is no provision for late filings. An application received on November 16th is automatically disqualified, regardless of the merit of the research.6

Economic Impact and Statistical Analysis of the Credit

The Maryland R&D credit is a primary lever of the state’s economic development strategy. Reports from the Department of Commerce and the Comptroller’s Office provide insights into how these funds are distributed across the economy.

Participation Trends

The program consistently hits its $12 million cap, reflecting a high level of engagement from the private sector.1 While the exact number of applicants varies by year, the biotechnology and life science sectors in Montgomery and Frederick Counties, along with the cybersecurity hub in the Baltimore-Washington corridor, are the primary users of the credit.1

The 2024 Evaluation and Future Policy

The Department of Legislative Services (DLS) is scheduled to release a comprehensive evaluation of the R&D credit in late 2024.22 This report will examine the fiscal impact of the credit and whether it has successfully fostered the “turbocharged economy” envisioned by the state administration.23 One area of focus is expected to be the efficacy of the $3.5 million small business set-aside. Policymakers are keen to determine if the $5 million asset cap is still the appropriate threshold for defining a “small” innovator in an era of high-cost laboratory equipment and rapid technological scaling.22

Conclusion: Strategic Implications for Maryland Innovators

The Maryland Research and Development Tax Credit represents a high-value but administratively demanding incentive for pass-through entities. For the forward-thinking PTE, the credit is more than a year-end tax benefit; it is a mechanism to lower the effective cost of labor and supplies, thereby accelerating the pace of technical discovery. The structural transparency of PTEs ensures that these state-funded incentives directly benefit the individuals and investors who drive Maryland’s innovation economy.

However, the complexity of the “Growth” calculation, the nuances of the small business asset test, and the absolute rigidity of the November 15th application deadline require a proactive compliance strategy. Pass-through entities must maintain rigorous, project-based accounting throughout the year to ensure they can substantiate their Maryland-sourced expenses. Furthermore, the interplay between the Department of Commerce’s certification and the Comptroller’s “add-back” and amended return requirements necessitates close coordination between a company’s R&D teams and its tax advisors. As the program evolves toward its 2027 sunset, Maryland’s pass-through entities remain at the forefront of the state’s efforts to maintain its position as a global leader in science and technology. By successfully navigating this regulatory landscape, these businesses can effectively monetize their innovation and fuel the next generation of Maryland-born breakthroughs.

R&D Tax Credit Preparation Services

Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.

If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.

R&D Tax Credit Audit Advisory Services

creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.

Our Fees

Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/